Prepared for Alaska Heart & Vascular Institute · 2027 Strategy Review · Confidential
Heart Failure · Hypertension · Envoy Integrated Health ACO · Anchorage, Alaska

2027 Remote Care Overview and Value Analysis for Alaska Heart & Vascular Institute

A scalable, profitable remote care service line for Alaska Heart & Vascular Institute: remote monitoring and principal care management for heart failure and hypertension, sorted by Envoy attribution, billed under AHVI’s own NPIs, run by a CoachCare care team inside athenahealth, and live February 1, inside the first ASM performance year.

Highlights of a Unified Remote Care Service Line

$0
Contribution margin over 36 months
0
Enrolled patients at 36 months
$0
Year 3 contribution margin
0
Projected hospitalizations avoided
0
AHVI cardiologists in the ASM heart failure cohort
BP · Weight · Symptoms
Care gaps closed between visits
0
New AHVI staff needed
01Progress So Far

What AHVI and CoachCare Have Built Together Since August

Three months ago this was a whole-panel estimate. It is now a deployment plan built on AHVI’s own census, Envoy’s own attribution report and the final 2027 fee schedule, with a go-live date. Each step below changed the plan.

August

AHVI’s census replaced our estimate

AHVI pulled its Medicare census in three groups: heart failure only, hypertension only, and both. That gave us 17,049 patients, 5,038 with heart failure and 12,011 with hypertension and no heart failure. Every figure on this page starts there.

August 20 · Anchorage

A day on site with AHVI’s team

CoachCare’s leadership and clinical team worked through the Alaska questions in person: statewide device shipping and connectivity, the on-site enrollment specialist role, care management and escalation protocols, and the closed-loop athenahealth integration.

Late August

Scoped to heart failure and hypertension, sorted by Envoy attribution

AHVI founded Envoy Integrated Health ACO, so a care-management dollar spent on an attributed patient also lands in Envoy’s benchmark. We checked Envoy’s financial and quality results against CMS’s public files, then split the panel into three lanes by who carries the economics.

September

Envoy’s own report settled the attribution question

Envoy’s August 2026 report attributes 809 AHVI patients, 4.7% of the 17,049. That replaced our placeholder and shrank the ACO question to a small post-discharge slice.

September 30

Three enrollment options for ACO-attributed patients

Exclude them entirely, enroll them only after a heart failure discharge, or enroll every heart failure patient with no screen. This plan uses the second option. The first stays available as a fallback.

November

An implementation plan built on the final rule

The week CMS finalized the 2027 fee schedule, we built a dated go-live plan for the first ASM performance year. It is section 03 below, now set for February 1 to leave room for onboarding around the holidays.

What the Envoy Analysis Showed
4.7%
809 of 17,049 AHVI heart failure and hypertension patients are Envoy-attributed, per Envoy’s August 2026 report.
$0
Added to Envoy’s benchmark by the two non-attributed lanes, which hold 95.3% of patients.
$125K
Net total-cost-of-care benefit to Envoy over 36 months from post-discharge heart failure enrollment. Value to Envoy, kept out of every AHVI figure.
7.12 pts
Of cushion left above Envoy’s minimum savings rate. The program uses 0.12 points of benchmark.
FallbackExclude ACO-attributed patients entirely→$0 impact on Envoy
The ACO question is answered. Enrollment adds nothing to Envoy’s benchmark for 95% of patients, and the post-discharge slice saves Envoy more than it costs.
02CY2027 Final Rule

The Final Rule Does Not Materially Change Our Partnership. We Are Clear to Proceed.

CMS finalized the 2027 Physician Fee Schedule in November. It keeps remote monitoring open, holds the rates for the clinical work and adds one guardrail at enrollment. Every figure on this page is at the final 2027 rates for Anchorage.

Initiating visit
Starts Jan 1
New RPM patients need a face-to-face visit, in person or by telehealth, where the billing practitioner discusses monitoring. A regular visit counts.
Device supply · 99445 / 99454
Steps down
Lower in 2027 under a statutory phase-in. CMS said it lacks good cost data for these devices and will revisit them after the January 2027 RUC review.
Monitoring and care management
Essentially flat
The time-based codes for the clinical work, where most of the value sits, move by about a dollar or two.
Clinical staffing
No change for 2027
CMS will work out staffing arrangements with stakeholders before changing anything. CoachCare care managers staff RPM as they do today.
Four-code RPM bundle
Not adopted
Left for future rulemaking. Today’s RPM codes stay in place.
“Intended to preserve access to appropriate RPM and RTM services.”CMS, CY2027 Physician Fee Schedule final rule, p. 275
Anchorage rates, before and after
CodeService20262027 final
99453RPM setup and education$22.78$20.70
99445RPM device supply, 2–15 days$55.32$42.95
99454RPM device supply, 16–30 days$55.32$42.95
99470RPM management, first 10 min$31.91$31.93
99457RPM management, first 20 min$63.31$62.53
99458RPM management, each extra 20 min$52.29$51.58
99426PCM, first 30 min$85.54$83.31
99427PCM, each extra 30 min$67.08$66.05
99495TCM, moderate complexity$271.55$260.75
99496TCM, high complexity$368.96$355.16
What it means for AHVI
Workflow
One flag. The initiating visit goes into the clinic workflow in January, so the first enrollments in February come out of visits AHVI is already holding.
Economics
Positive from the first month: +$15,543 of contribution margin in month one and $1.05M across the first 12 months, at final 2027 rates.
Plan
Unchanged. Same three lanes, same post-discharge rule for Envoy patients, and a February 1 start. The only addition is ACCESS, below.
Higher acuity · RPM + principal care management

Heart failure stays on remote monitoring

Readings reviewed by CoachCare nurses, with monthly care management around them. CMS kept RPM for these patients, and advanced heart failure (NYHA III–IV) is excluded from ACCESS, so AHVI’s ASM cohort stays on RPM.

Lower acuity · ACCESS, new in 2027

A second lane for hypertension and cardiometabolic patients

CMS’s voluntary ACCESS model pays about $420 a year per patient on its cardio-kidney-metabolic track, part of it tied to outcomes. In the first quarter of 2027 we review which AHVI hypertension patients fit ACCESS better than RPM and decide together whether to apply.

The final rule does not materially alter the proposed partnership with CoachCare. We are clear to proceed.Nothing in it changes the deployment design, the Envoy approach or the timeline, and the contribution margin on this page is already at the final 2027 rates.
03Implementation, Integration and Onboarding

Live February 1, With Room to Onboard Around the Holidays

Five stages to a February 1 go-live, with the holiday weeks kept light so onboarding never competes with year-end. CoachCare runs the build inside athenahealth. AHVI’s cardiologists make every clinical call.

1
By November 20

Decide

  • Sign the agreement
  • Name an executive sponsor and a physician lead
  • Confirm which athena system we connect to on day one
AHVI leads
2
Late Nov – mid Dec

Kick off and connect

  • Executive kickoff
  • athena integration request filed
  • Heart failure patient report pulled from the EHR
  • Provider roster loaded
CoachCare leads
3
Dec – early Jan

Configure

  • Enrollment criteria and SOPs signed off
  • Initiating-visit flag added to the clinic workflow
  • Eligible-patient list approved
  • Cellular devices staged for statewide shipping
Joint · physician lead approves
4
Mid – late Jan

Train and test

  • 30-minute provider in-service
  • Front-desk and scheduling walkthrough
  • End-to-end test: flag, visit, device, reading, claim
CoachCare leads
5
February 1, 2027

Go live

  • Initiating visits and enrollments start
  • Devices ship within days of enrollment
  • Care managers begin outreach
  • First claims in March
ASM year 1 is counting
What we need from AHVI
  • A signatory and an executive sponsor
  • A physician lead to approve enrollment criteria and SOPs
  • An athena administrator contact and the athenaOne cutover date
  • 30 minutes from each physician for the in-service
  • A front-desk owner for the initiating-visit flag
What CoachCare carries
  • Care managers and the two on-site enrollment specialists
  • Enrollment outreach, devices and statewide logistics
  • The athenahealth integration, both directions
  • Billing documentation, claims ready in athenahealth
  • Monthly reporting, with no new hires and no capital outlay for AHVI
Every month
Operating review with the physician lead: enrollment, device adherence, billing, and heart failure admissions against the ASM cost measure.
Q1 2027
ACCESS fit review for hypertension and cardiometabolic patients, and a decision on whether to apply.
Jan 1, 2027
ASM year 1 starts. Every 2027 heart failure patient counts toward AHVI’s score.
Dec 31, 2027
Year 1 closes. The score is half quality, half heart failure cost.
The next step is a signed agreement and two names: an executive sponsor and a physician lead. Everything after that is on the schedule above.
04Why Now

Ten AHVI Cardiologists Are in the ASM Heart Failure Cohort From January 1

CMS’s final participant list, posted September 17, puts ten AHVI cardiologists in the Ambulatory Specialty Model’s heart failure cohort, on a historical Part B base of about $4.65M. Performance in 2027 sets a two-sided payment adjustment in 2029, and the range widens every year after. The monitoring, post-discharge follow-up and longitudinal management in this plan are the work ASM measures.

Performance 2027
paid in 2029
±9%
selected scenario +$189K
Performance 2028
paid in 2030
±9%
selected scenario +$192K
Performance 2029
paid in 2031
±10%
selected scenario +$218K
Performance 2030
paid in 2032
±11%
selected scenario +$245K
Performance 2031
paid in 2033
±12%
selected scenario +$272K
Exposure base

AHVI cardiologists on the final list

ASM adjusts covered professional Part B payments broadly, not only remote care claims. That is why the exposure base is $4.65M rather than the program’s own billing.

Clinical-economic bridge
1.034 → 0.974

Observed-to-expected heart failure cost

Fewer inpatient and emergency events from the two heart failure lanes, at a 60% ASM-managed share of the census. A direction, not a predicted CMS score.

Selected scenario
~$1.12M

Five payment years, 2029 to 2033

Only the 2029 payment (~$189K) falls inside the 36-month window. At a zero score the first-year downside is $444K, which is the case for having the workflow live early in the year.

The fee-for-service case stands on its own. ASM raises the value of the same heart failure infrastructure. It does not have to justify it.
05The Practice

17,049 Medicare Patients, Sorted by Who Carries the Economics

For a patient outside any ACO benchmark, every dollar of RPM and PCM margin is AHVI’s to keep. For a patient Envoy is accountable for, the same dollar also raises Envoy’s benchmark, and the program has to avoid enough admissions to pay that back. AHVI is a specialty practice, so patients attribute to their primary care physicians and the attributed slice is small. The non-attributed lanes carry the deployment.

The question

Is the patient Envoy-attributed?

Envoy assigns retrospectively, so the working filter is the referring primary care physician: the six Envoy primary care TINs. Roughly one patient in twenty sits inside the benchmark.

Outside the benchmark

Enroll broadly. The margin is AHVI’s.

Non-attributed heart failure and hypertension patients bill RPM and PCM with no ACO exposure. These two lanes run at full enrollment-specialist capacity from month one.

Inside the benchmark

Enroll after a discharge.

A post-discharge heart failure cohort avoids enough admissions to outrun the care-management spend it adds to Envoy’s benchmark. Attributed patients enter through a qualifying discharge, not a panel sweep.

Lane A
Non-attributed Heart Failure
Who
Heart failure patients whose primary care physician is not in an Envoy TIN
Program
RPM + PCM for every enrolled patient
Deployment
Broad · ~4,799 available · ~1,680 census ceiling
$3.91M
36-month contribution margin
Lane B
Envoy-attributed Heart Failure
Who
Attributed heart failure patients after a qualifying acute discharge
Program
TCM + 12 months of RPM + PCM
Deployment
Post-discharge only · ~42 patients at steady state
$126K
36-month contribution margin · plus $125K net benefit to Envoy
Lane C
Non-attributed Hypertension
Who
Hypertension without heart failure, outside the Envoy benchmark, with an active management need
Program
RPM + PCM on the documented uncontrolled slice
Deployment
Broad · ~11,440 pool · ~3,432 census ceiling
$3.57M
36-month contribution margin
Scale where AHVI keeps the economics. Enroll selectively where program spend enters Envoy’s benchmark. About 98% of contribution margin comes from the two non-attributed lanes.
06Operating Model

Two On-Site Enrollment Specialists, About 160 New Patients a Month

Two dedicated enrollment specialists, hired in Anchorage and paid by CoachCare, each with capacity for about 80 enrollments a month. One runs heart failure and staffs the post-discharge window first. The other runs hypertension.

Enrollment specialist 1 · Heart failure

~80 enrollments a month, post-discharge first

Lane B, about 4 a month. The post-discharge window is short, so these patients are staffed first.

Lane A, the rest. Non-attributed heart failure takes the remaining capacity until it reaches its 1,680 ceiling in month 27, then drops to replacement enrollment.

Enrollment specialist 2 · Hypertension

~80 enrollments a month, all Lane C

Against a 11,440-patient pool and a 3,432 ceiling, 80 a month less attrition reaches about 2,238 active patients by month 36. Enrollment capacity, not the population, is the limit on this lane.

What AHVI Invests
No upfront capital, no hiring and no device purchase. Implementation and the athenahealth integration build are included. AHVI bills under its own NPIs and keeps the payer relationship.
What AHVI Staffs
Nothing new. Enrollment, device logistics including bush shipping, consent and monthly care management are on CoachCare’s payroll. AHVI’s clinicians keep the escalation decisions and sign the care plans.
What Runs the Ramp
About 160 new enrollments a month across the three lanes, tapering as Lane A fills. Active census reaches 1,767 patients at month 12, 3,209 at month 24 and 3,960 at month 36, net of attrition.
athenahealth, Both Ways
Readings, care-plan time and billing-ready documentation land in the chart AHVI already uses. Both athenaPractice and athenaOne are supported, so the migration is not a reason to wait.
07Value Analysis

Contribution Margin on AHVI’s Own Census, at Final 2027 Rates

A 36-month forecast of the three lanes on AHVI’s census at Anchorage Medicare rates, launching February 2027, inside the first ASM performance year. Contribution margin is what AHVI keeps.

Active Census by Lane

Patients in active remote care at month end. Lane A reaches its 1,680 ceiling by month 27; Lane B holds near 42; Lane C is still climbing at month 36, at 2,238 of a 3,432 ceiling.

Monthly Contribution Margin

Positive in month one (+$15,543) and every month after, reaching about $343K a month by month 36.

36-Month Contribution Margin by Lane

$7.61M in total. The two non-attributed lanes carry about 98% of it.

Contribution Margin by Year

LaneYear 1Year 2Year 336-Month
Lane A · non-attributed HF$551,045$1,431,419$1,931,278$3,913,742
Lane B · attributed HF$28,081$49,113$49,192$126,386
Lane C · non-attributed HTN$473,586$1,231,427$1,863,567$3,568,580
Contribution margin, all lanes$1,052,712$2,711,959$3,844,037$7,608,708
The Investment Case

Self-Funding From Month One, With No Upfront Capital

Cost scales with the patients on program, so there is no payback period to finance and no month in which cumulative contribution margin is negative.

Upfront
$0
No capital, devices or hiring
Month 1
+$16K
Contribution margin in the first month
Month 12 · cumulative
$1.05M
1,767 patients active
Month 36 · cumulative
$7.61M
~$343K a month by then

Cumulative Contribution Margin

Milestones at months 12, 24 and 36.
Contribution margin, 36 months$7.61M
plus the 2029 ASM payment (selected scenario)$189K
plus Envoy participant distributions to AHVI$1K
Total modeled AHVI value, 36 months$7.80M
Kept separate: $125K of net total-cost-of-care benefit to Envoy. It matters to the enterprise relationship and is not counted as AHVI value anywhere on this page.

Scenario Explorer: The Non-Attributed Lanes

Lanes A and C, the non-attributed heart failure and hypertension patients with no ACO exposure. Recomputed live with the same lane mechanics and the same final 2027 rates as the forecast: each enrollment specialist supplies 80 enrollments a month, referring providers supply eight referrals a month each at 80% acceptance, and every lane stops at its ceiling or its pool.
36-mo contribution margin · A + C
–
Active patients · month 36
–
Month-1 contribution margin
–
HF admissions avoided · Lane A · 36 mo
–

Referring providers set the referral supply. The starting 25 providers supply about 160 a month, which is the two specialists’ capacity, so fewer providers or another specialist makes referrals the limit. The starting 12-month ramp is slower than the forecast above, which runs at full pace from month one. Penetration and enrollment rate set each lane’s ceiling; the specialists set how fast the lane climbs toward it.

~561

HF Admissions Avoided

Across the two heart failure lanes over 36 months, at a 40% reduction on a 40% annual admission rate. Lane C claims margin only.

~21

Lane B Admissions Avoided

The attributed post-discharge cohort alone, with about 12 emergency visits avoided beside them.

Lane A Patients Enrolled

Over 36 months, beside 140 post-discharge enrollments in Lane B and 2,880 in Lane C.

Modeled Horizon

Monthly for all three lanes from a February 2027 go-live, at final 2027 rates throughout.

Envoy’s ledger

Post-Discharge Enrollment Pays Its Way Inside Envoy’s Benchmark

Every Lane B care-management dollar raises Envoy’s benchmark. Enrolling after a discharge lets avoided admissions and emergency visits outweigh that spend, so Envoy’s total cost of care improves while AHVI still earns margin on the lane.

Added to the benchmark
~$88K

a year at steady state

0.12 points of Envoy’s benchmark, against a 1.5-point budget.

Avoided utilization
~$141K

a year at steady state

From admissions and emergency visits avoided on a ~42-patient census.

Net benefit to Envoy

a year · $125K over 36 months

The lane needs 13.2 avoided admissions per 100 patient-years to break even; the modeled cohort delivers 20.

PCM share on Lane B0%25%50%70% · modeled100%
Added to Envoy’s benchmark0.08 pts0.09 pts0.11 pts0.12 pts0.14 pts
Net benefit to Envoy+$85K/yr+$74K/yr+$62K/yr+$52K/yr+$38K/yr
Avoided admissions per 100 needed to break even8.3 of 2010.0 of 2011.8 of 2013.2 of 2015.3 of 20
AHVI contribution margin, Lane B$29K/yr$36K/yr$43K/yr$49K/yr$58K/yr
08Why CoachCare

Why Work with CoachCare?

In Alaska a remote care program fails at the seams: a ten-day transit to a village post office, a community without LTE, an EHR migration in flight. One partner has to carry the whole set.

One partner, the whole stack

Vertically integrated

Platform, cellular devices and SIMs, device logistics, a US-based W-2 care team, billing and analytics, all run by CoachCare. Devices arrive configured and transmit over cellular with no smartphone, app or home internet, which is what makes the program statewide.

Cardiology is the specialty

Built with large cardiology groups

60+ ambulatory cardiology sites, including Cardiac Solutions, Western Washington Medical Group, MercyOne Iowa Heart and AMS Cardiology. Cardiology protocols, a five-rung escalation ladder and a fixed three-touch post-discharge sequence AHVI signs before go-live.

athenahealth, both ways

Bi-directional on athenaOne

Eligibility flags surface candidates in the chart, readings and care-plan time write back, and claims generate into athenahealth. athenaPractice and athenaOne are both supported.

Physicians stay in charge

AHVI supplies the clinical authority

A named care team staffed to AHVI and trained on AHVI’s protocols, at a 160:1 ratio rather than the 300:1 common in the market. Only two things come back to an AHVI clinician: the exceptions, and the claim.

Connective tissue

The same patients feed the procedural lines

Symptom and vitals trends surface progression in monitored aortic stenosis patients. Post-discharge weight and pressure are tracked after CABG and PCI. Device-captured blood pressure over time is the evidence a renal denervation referral needs.

Published results

On AHVI’s two conditions

A 29.1 mmHg average drop in Stage 2 hypertension across 2,738 patients at Cardiac Solutions (case study). Zero 30-day readmissions across six months among 450 advanced heart failure patients at Iowa Heart (case study). 74% fewer admissions in six months at Advocate Aurora (case study).

500,000+
Patients managed across 400+ conditions
10,000+
Clinicians on the platform
1,000+
Programs stood up and running
5M+
Claims generated
100M+
Vitals recorded
The ask: sign by November 20 and name an executive sponsor and a physician lead, so kickoff lands in late November and the first patients enroll February 1.